The neurotensin C-terminal pentapeptide has been systematically simplified to identify a minimal fragment with in vivo analgesic activity and neurotensin receptor binding ability. Di-, tri-, and tetrapeptide fragments were inactive. Pentapeptide simplifications established that only the arginine could be replaced with simpler amino acids and retain activity in each assay.